MCID: FLL028
MIFTS: 20

Fallopian Tube Carcinosarcoma

Categories: Cancer diseases, Reproductive diseases

Aliases & Classifications for Fallopian Tube Carcinosarcoma

MalaCards integrated aliases for Fallopian Tube Carcinosarcoma:

Name: Fallopian Tube Carcinosarcoma 12 15 73
Fallopian Tube Malignant Mixed Mesodermal Tumor 12
Fallopian Tube Malignant Mixed Mullerian Tumor 12

Classifications:



External Ids:

Disease Ontology 12 DOID:1970
NCIt 50 C40124
UMLS 73 C1517117

Summaries for Fallopian Tube Carcinosarcoma

Disease Ontology : 12 A fallopian tube cancer that is characterized as a mixture of carcinoma and sarcoma and has material basis in epithelial tissue and has material basis in connective tissue.

MalaCards based summary : Fallopian Tube Carcinosarcoma, also known as fallopian tube malignant mixed mesodermal tumor, is related to venous hemangioma and adenomatoid tumor. An important gene associated with Fallopian Tube Carcinosarcoma is WT1 (Wilms Tumor 1), and among its related pathways/superpathways is Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Bevacizumab and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include endothelial.

Related Diseases for Fallopian Tube Carcinosarcoma

Graphical network of the top 20 diseases related to Fallopian Tube Carcinosarcoma:



Diseases related to Fallopian Tube Carcinosarcoma

Symptoms & Phenotypes for Fallopian Tube Carcinosarcoma

Drugs & Therapeutics for Fallopian Tube Carcinosarcoma

Drugs for Fallopian Tube Carcinosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 17)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bevacizumab Approved, Investigational Phase 1 216974-75-3
2
Carboplatin Approved Phase 1 41575-94-4 10339178 498142 38904
3
Cisplatin Approved Phase 1 15663-27-1 84093 441203 2767
4
Paclitaxel Approved, Vet_approved Phase 1 33069-62-4 36314
5
Veliparib Investigational Phase 1 912444-00-9 11960529
6 Albumin-Bound Paclitaxel Phase 1
7 Angiogenesis Inhibitors Phase 1
8 Angiogenesis Modulating Agents Phase 1
9 Antibodies Phase 1
10 Antibodies, Monoclonal Phase 1
11 Antimitotic Agents Phase 1
12 Antineoplastic Agents, Phytogenic Phase 1
13 Endothelial Growth Factors Phase 1
14 Immunoglobulin G Phase 1
15 Immunoglobulins Phase 1
16 Mitogens Phase 1
17 Poly(ADP-ribose) Polymerase Inhibitors Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Active, not recruiting NCT00989651 Phase 1 Carboplatin;Cisplatin;Paclitaxel;Veliparib

Search NIH Clinical Center for Fallopian Tube Carcinosarcoma

Genetic Tests for Fallopian Tube Carcinosarcoma

Anatomical Context for Fallopian Tube Carcinosarcoma

MalaCards organs/tissues related to Fallopian Tube Carcinosarcoma:

41
Endothelial

Publications for Fallopian Tube Carcinosarcoma

Variations for Fallopian Tube Carcinosarcoma

Expression for Fallopian Tube Carcinosarcoma

Search GEO for disease gene expression data for Fallopian Tube Carcinosarcoma.

Pathways for Fallopian Tube Carcinosarcoma

Pathways related to Fallopian Tube Carcinosarcoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.75 NCAM1 WT1

GO Terms for Fallopian Tube Carcinosarcoma

Sources for Fallopian Tube Carcinosarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....